MedTrace Logo

Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program

NCT04616651 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2022-08-11

No results posted yet for this study

Summary

This study is designed to study the feasibility and acceptability of the Open to Options (O2O) Chatbot prototype. The O2O program is an existing patient support program with content currently delivered via in-person counseling with a trained mental health professional or via an existing web-based program (Let's Talk Treatment Options).The Chatbot is an automated, menu-based agent being developed in this study to extend the reach and accessibility of the O2O program via the Chatbot's "virtual coaching".

Conditions

Interventions

BEHAVIORAL

Online Survey

Participants respond to online survey questions either before or after using the Chatbot O2O intervention.

BEHAVIORAL

Chatbot prototype

An online, automated, menu-based agent in which all responses are pre-programmed to be consistent with the existing O2O program. The chat-like responses help guide the participant through a process with the goal of developing a list of questions for their upcoming appointment with a cancer clinician. The session is meant to be completed in one sitting and estimated to take about 45 minutes to complete (including the pre- or post-intervention survey); however, if a participant stops in the middle, they may go back and complete the Chatbot session (or survey).

BEHAVIORAL

Open to Options (O2O) Program

Evidence-based program developed by Cancer Support Community that helps patients actively engage in their treatment decision process by preparing them for their upcoming appointments.

Sponsors & Collaborators

  • Cancer Support Community

    collaborator UNKNOWN

  • University of Michigan Rogel Cancer Center

    lead OTHER

Principal Investigators

  • Sarah Hawley, PhD, MPH · University of Michigan Rogel Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-25
Primary Completion
2021-08-10
Completion
2021-08-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04616651 on ClinicalTrials.gov